Mannkind (MNKD) Accumulated Expenses (2010 - 2026)
Mannkind's (MNKD) quarterly Accumulated Expenses came in at $1.8 million in Q1 2026, down 91.14% year-on-year from $20.6 million in Q1 2025, and down 93.4% on a QoQ basis from $27.6 million in Q4 2025.
Mannkind (MNKD) Accumulated Expenses (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Accumulated Expenses data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses fell 91.14% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 91.14% decrease from a year earlier, with the FY2025 full-year figure at $27.6 million, down 31.39% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $1.8 million, down from $27.6 million in the prior quarter.
- Over the last five years, Accumulated Expenses for MNKD reached as high as $40.3 million in Q4 2024 and fell as low as $168000.0 in Q1 2023.
- Historically, Accumulated Expenses has averaged $11.6 million across 5 years, with a median of $6.2 million in 2024.
- Across the five-year window, Accumulated Expenses slumped 98.51% in 2023 and soared 12293.45% in 2024, its largest moves.
- Year by year, Accumulated Expenses stood at $14.9 million in 2022, then plunged by 85.56% to $2.2 million in 2023, then jumped by 1771.48% to $40.3 million in 2024, then plunged by 31.39% to $27.6 million in 2025, then plunged by 93.4% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $1.8 million in Q1 2026, $27.6 million in Q4 2025, and $31.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 27.65 Mn |
| Sep 30, 2025 | 31.42 Mn |
| Jun 30, 2025 | 303,000.00 |
| Mar 31, 2025 | 20.59 Mn |
| Dec 31, 2024 | 40.29 Mn |
| Sep 30, 2024 | 479,000.00 |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 20.82 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 173,000.00 |
| Jun 30, 2023 | 12.14 Mn |
| Mar 31, 2023 | 168,000.00 |
| Dec 31, 2022 | 14.91 Mn |
| Sep 30, 2022 | 11.63 Mn |
| Jun 30, 2022 | 6.07 Mn |
| Mar 31, 2022 | 729,000.00 |
| Dec 31, 2021 | 14.02 Mn |
| Sep 30, 2021 | 20.83 Mn |
| Jun 30, 2021 | 1.06 Mn |